Study title:
Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Virus Diseases [C02]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Foscarnet |
ATC code: |
Document link:
Ippoliti C et al 1997.pdf
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
Y
|